Pay vs Performance Disclosure - USD ($)

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Pay vs Performance Disclosure [Table]

Pay Versus Performance



					Value of Initial Fixed $100 Investment Based on:


Year	Summary Compensation Table Total for PEO ($)(1)	Compensation Actually Paid to PEO ($)(2)	Average Summary Compensation Table Total for Non-PEO Named Executive Officers ($)(3)	Average Compensation Actually Paid to Non-PEO Named Executive Officers ($)(2)	Total Shareholder Return ($)(4)	NAREIT Health Care Total Shareholder Return ($)(5)	Net Income ($)(6)	Adjusted Normalized FFO Per Share ($)((7)(8)

2022	6,652,517	7,288,778	2,414,421	2,550,429	58.25	81.59	-77.6	$1.5363

2021	6,091,584	1,132,584	1,741,895	447,643	63.45	104.85	-113.3	$1.6167

2020	5,455,333	3,045,161	2,119,717	1,172,025	81.40	90.14	138.4	$1.820

(1)

Reflects compensation amounts reported in the Summary Compensation Table for our Chairman and Chief Executive Officer, Richard K. Matros, for the respective years shown.

(2)

The dollar amounts reported represent the amount of “compensation actually paid” to our Chairman and

Chief

Executive Officer and the average of

non-Chief

Executive Officer Named Executive Officers, as computed in accordance with Item 402(v) of Regulation

S-K.

The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with the requirements of Item 402(v) of Regulation

S-K,

the following adjustments were made to total compensation for each year to determine the compensation actually paid:


	2020		2021		2022
Adjustments	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs

Reported Summary Compensation Table Total	$5,455,333	$2,119,717	$6,091,584	$1,741,895	$6,652,517	$2,414,421

Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY	($3,517,458)	($1,407,392)	($4,047,334)	($977,678)	($4,129,117)	($1,352,381)

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End	$3,409,048	$1,071,410	$3,790,585	$681,645	$4,071,408	$1,241,284

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date	–	$332,495	–	$193,896	–	$74,929

Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End	($1,297,659)	($458,766)	($2,169,499)	($533,341)	$629,203	$159,830

Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date	($1,004,103)	($485,439)	($2,532,752)	($658,774)	$64,767	$12,346

Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End	–	–	–	–	–	–

Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date	–	–	–	–	–	–

Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY	–	–	–	–	–	–

TOTAL ADJUSTMENTS	($2,410,172)	($947,692)	($4,959,000)	($1,294,252)	$636,261	$136,008

COMPENSATION ACTUALLY PAID	$3,045,161	$1,172,025	$1,132,584	$447,643	$7,288,778	$2,550,429

(3)

The following are our

non-Chief

Executive Officer Named Executive Officers for each of the years reflected in the table above:

2022: Talya Nevo-Hacohen and Michael Costa

2021: Talya Nevo-Hacohen, Michael Costa and Harold Andrews

2020: Talya Nevo-Hacohen and Harold Andrews

(4)

Cumulative total shareholder return is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between Sabra’s share price at the end and the beginning of the measurement period by Sabra’s share price at the beginning of the measurement period.

(5)

Peer group used for this purpose is the following published industry index: Nareit Health Care Property Sector Total Return Index.

(6)

The dollar amounts reported represent the amount of net income in millions reflected in the Company’s audited financial statements for the applicable year.

(7)

Financial Performance Measures. Listed below are the financial performance measures which in our assessment represent the most important financial performance measures we use to link compensation actually paid to our Named Executive Officers, for 2022, to Sabra’s performance:

Adjusted Normalized FFO Per Share

Total Shareholder Return

(8)

Below are graphs showing the relationship of “compensation actually paid” to our Chief Executive Officer and other Named Executive Officers in 2020, 2021 and 2022 to (1) TSR of both Sabra and the Nareit Health Care Property Sector Total Return Index, (2) Sabra’s net income and (3) Sabra’s adjusted normalized FFO per share.

Company Selected Measure Name

Adjusted Normalized FFO Per Share

Named Executive Officers, Footnote [Text Block]

(3)

The following are our

non-Chief

Executive Officer Named Executive Officers for each of the years reflected in the table above:

2022: Talya Nevo-Hacohen and Michael Costa

2021: Talya Nevo-Hacohen, Michael Costa and Harold Andrews

2020: Talya Nevo-Hacohen and Harold Andrews

Peer Group Issuers, Footnote [Text Block]

Peer group used for this purpose is the following published industry index: Nareit Health Care Property Sector Total Return Index.

PEO Total Compensation Amount

$ 6,652,517

$ 6,091,584

$ 5,455,333

PEO Actually Paid Compensation Amount

$ 7,288,778

1,132,584

3,045,161

Adjustment To PEO Compensation, Footnote [Text Block]


	2020		2021		2022
Adjustments	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs

Reported Summary Compensation Table Total	$5,455,333	$2,119,717	$6,091,584	$1,741,895	$6,652,517	$2,414,421

Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY	($3,517,458)	($1,407,392)	($4,047,334)	($977,678)	($4,129,117)	($1,352,381)

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End	$3,409,048	$1,071,410	$3,790,585	$681,645	$4,071,408	$1,241,284

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date	–	$332,495	–	$193,896	–	$74,929

Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End	($1,297,659)	($458,766)	($2,169,499)	($533,341)	$629,203	$159,830

Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date	($1,004,103)	($485,439)	($2,532,752)	($658,774)	$64,767	$12,346

Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End	–	–	–	–	–	–

Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date	–	–	–	–	–	–

Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY	–	–	–	–	–	–

TOTAL ADJUSTMENTS	($2,410,172)	($947,692)	($4,959,000)	($1,294,252)	$636,261	$136,008

COMPENSATION ACTUALLY PAID	$3,045,161	$1,172,025	$1,132,584	$447,643	$7,288,778	$2,550,429

Non-PEO NEO Average Total Compensation Amount

$ 2,414,421

1,741,895

2,119,717

Non-PEO NEO Average Compensation Actually Paid Amount

$ 2,550,429

447,643

1,172,025

Adjustment to Non-PEO NEO Compensation Footnote [Text Block]


	2020		2021		2022
Adjustments	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs	PEO	Average non- PEO NEOs

Reported Summary Compensation Table Total	$5,455,333	$2,119,717	$6,091,584	$1,741,895	$6,652,517	$2,414,421

Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY	($3,517,458)	($1,407,392)	($4,047,334)	($977,678)	($4,129,117)	($1,352,381)

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End	$3,409,048	$1,071,410	$3,790,585	$681,645	$4,071,408	$1,241,284

Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date	–	$332,495	–	$193,896	–	$74,929

Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End	($1,297,659)	($458,766)	($2,169,499)	($533,341)	$629,203	$159,830

Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date	($1,004,103)	($485,439)	($2,532,752)	($658,774)	$64,767	$12,346

Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End	–	–	–	–	–	–

Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date	–	–	–	–	–	–

Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY	–	–	–	–	–	–

TOTAL ADJUSTMENTS	($2,410,172)	($947,692)	($4,959,000)	($1,294,252)	$636,261	$136,008

COMPENSATION ACTUALLY PAID	$3,045,161	$1,172,025	$1,132,584	$447,643	$7,288,778	$2,550,429